Atlas Trials

A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT07622186 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07622186
Sponsor
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer
Start date
2026-07-31
Primary completion
2028-12-31
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.